Key result
Tirofiban and abciximab were associated with severe pulmonary hemorrhage in three patients, including the first reported case linked to tirofiban.
Why the study?
Does administration of tirofiban or abciximab cause severe pulmonary hemorrhage in patients?
Population
3 patients receiving platelet glycoprotein IIb/IIIa inhibitors
Design
Case_series
Authors
Loading...
Warrants vigilance for pulmonary hemorrhage with these agents; case reports leave incidence and causality open.
Does administration of tirofiban or abciximab cause severe pulmonary hemorrhage in patients?
This report highlights severe pulmonary hemorrhage as a rare but significant complication of platelet glycoprotein IIb/IIIa inhibitors, including the first reported case associated with tirofiban.
Ali et al. (2000) studied this question. Tirofiban and abciximab were associated with severe pulmonary hemorrhage in three patients, including the first reported case linked to tirofiban.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: